MetaADEDB 2.0 @ LMMD
tafamidis
(TXEIIPDJKFWEEC-UHFFFAOYSA-N)
Structure
SMILES
Clc1cc(Cl)cc(c1)c1nc2c(o1)cc(cc2)C(=O)O
Type(s)
Approved; Investigational
ATC code(s)
N07XX08
Molecular Formula:
C14H7Cl2NO3
Molecular Weight:
308.116
Log P:
4.4998
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
63.33
CAS Number(s):
594839-88-0
Synonym(s)
1.
tafamidis
2.
FX 1006A
3.
FX-1006A
4.
FX1006A
5.
tafamidis meglumine
External Link(s)
MeSHC547076
PubChem Compound11001318
BindingDB50197883
ChEBI78538
CHEMBLCHEMBL2103837
DrugBankDB11644
DrugCentral4192
IUPHAR/BPS Guide to PHARMACOLOGY8378
KEGGdr:D09673
Therapeutic Target DatabaseD04DFR
ZINC43206271
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Burning sensationFAERS: 1US FAERS
2Disease ProgressionFAERS: 1US FAERS
3Foreign body in respiratory tractFAERS: 1US FAERS
4HypersensitivityFAERS: 1US FAERS
5Intentional product misuseFAERS: 1US FAERS
6Memory impairmentFAERS: 1US FAERS
7InfectionSIDER
8InfestationSIDER
9Urinary tract infectionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.